Description

NovoNorm (Repaglinide) tablets 2 mg. №30

Ingredients:

Each tablet contains 2 mg of Repaglinide.

Dosage:

The recommended dose is usually 0.5 mg to 4 mg taken before each main meal.

Indications:

NovoNorm tablets are indicated for the treatment of type 2 diabetes mellitus.

Contraindications:

Do not use NovoNorm if you have type 1 diabetes or diabetic ketoacidosis.

Directions:

Take NovoNorm exactly as prescribed by your healthcare provider. Follow all directions on your prescription label.

Scientific Evidence:

Repaglinide, the active ingredient in NovoNorm tablets, works by stimulating the release of insulin from the pancreas, helping to lower blood sugar levels. Studies have shown that Repaglinide is effective in controlling postprandial glucose levels in patients with type 2 diabetes.

Research published in the journal Diabetes Care demonstrated that Repaglinide, when compared to other oral antidiabetic agents, was effective in reducing HbA1c levels and improving glycemic control in diabetic patients.

Additional Information:

It is important to monitor your blood sugar levels regularly while taking NovoNorm to ensure it is effectively managing your diabetes. Inform your doctor about all other medications you are taking to avoid any potential drug interactions.

Consult your healthcare provider if you experience any side effects such as hypoglycemia, dizziness, or unusual sweating while using NovoNorm tablets.